E-Therapeutics Plc buy melinda
Start price
02.12.21
/
50%
€0.49
Target price
02.12.22
-
Performance (%)
-48.98%
End price
03.12.22
€0.25
Summary
This prediction ended on 03.12.22 with a price of €0.25. The BUY prediction by melinda for E-Therapeutics Plc performed very badly with a performance of -48.98%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
E-Therapeutics Plc | - | - | - |
iShares Core DAX® | 1.518% | 3.456% | 25.970% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% |
According to melinda what are the pros and cons of E-Therapeutics Plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread E-Therapeutics Plc diskutieren
Buy E-Therapeutics Plc
In the thread Trading E-Therapeutics Plc
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for E-Therapeutics Plc
E-Therapeutics Plc
Start price
Target price
Perf. (%)
€0.13
11.02.20
11.02.20
-
04.11.21
04.11.21
266.80%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year